Glucose homeostasis can be differentially modulated by varying individual components of a western diet

Journal of Nutritional Biochemistry

Volumn 24, Issue 7, 2013, Pages 1251-1257

  Forbes, Josephine M ^a,b,c   Cowan, Samantha P ^a,b   Andrikopoulos, Sofianos ^d   Morley, Amy L ^a   Ward, Leigh C ^e   Walker, Karen Z ^b   Cooper, Mark E ^a,b   Coughlan, Melinda T ^a,b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Advanced glycation end products; Glucose; Insulin; Macronutrients; Pancreas

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; PROTEIN; SATURATED FATTY ACID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOELECTRICAL IMPEDANCE SPECTROSCOPY; BLOOD SAMPLING; BODY COMPOSITION; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DIETARY INTAKE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FEEDING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HOMA IR; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID DIET; MALE; NONHUMAN; OBESITY; PROTEIN DIET; RAT; RATING SCALE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN DIET; ANIMAL; DIET; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; PANCREAS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; BODY COMPOSITION; DIET; GLUCOSE; HOMEOSTASIS; INSULIN RESISTANCE; MALE; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879296381     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.09.009     Document Type: Article

References (41)

1. World Health Organisation, International Diabetes Foundation Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia 2006, World Health Organisation, Geneva.
2. Fung T.T., McCullough M., van Dam R.M., Hu F.B. A prospective study of overall diet quality and risk of type 2 diabetes in women. Diabetes Care 2007, 30:1753-1757.
3. Fung T.T., Schulze M., Manson J.E., Willett W.C., Hu F.B. Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med 2004, 164:2235-2240.
4. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
5. Sandu O., Song K., Cai W., Zheng F., Uribarri J., Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005, 54:2314-2319.
6. O'Brien J., Morrissey P.A. Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr 1989, 28:211-248.
7. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997, 94:6474-6479.
8. Somoza V., Wenzel E., Weiss C., Clawin-Radecker I., Grubel N., Erbersdobler H.F. Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. Mol Nutr Food Res 2006, 50:833-841.
9. Thornalley P.J., Battah S., Ahmed N., Karachalias N., Agalou S., Babaei-Jadidi R., et al. Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 2003, 375:581-592.
10. Cai W., He J.C., Zhu L., Chen X., Zheng F., Striker G.E., et al. Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. Am J Pathol 2008, 173:327-336.
11. Hofmann S.M., Dong H.-J., Li Z., Cai W., Altomonte J., Thung S.N., et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002, 51:2082(8).
12. Coughlan M.T., Yap F.Y., Tong D.C., Andrikopoulos S., Gasser A., Thallas-Bonke V., et al. Advanced glycation end products are direct modulators of beta-cell function. Diabetes 2011, 60:2523-2532.
13. Peppa M., He C., Hattori M., McEvoy R., Zheng F., Vlassara H. Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice. Diabetes 2003, 52:1441-1448.
14. Zhao Z., Zhao C., Zhang X.H., Zheng F., Cai W., Vlassara H., et al. Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 2009, 150:2569-2576.
15. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 1993, 123:1939-1951.
16. Coughlan M.T., Thallas-Bonke V., Pete J., Long D.M., Gasser A., Tong D.C., et al. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?. Endocrinology 2007, 148:886-895.
17. Cefalu W.T., Wang Z.Q., Bell-Farrow A., Kiger F.D., Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 1994, 40:1317-1321.
18. Downie L.E., Vessey K., Miller A., Ward M.M., Pianta M.J., Vingrys A.J., et al. Neuronal and glial cell expression of angiotensin II type 1 (AT1) and type 2 (AT2) receptors in the rat retina. Neuroscience 2009, 161:195-213.
19. Ward L.C., Mason S., Battersby K.J. Bioimpedance spectroscopy for the measurement of body composition of laboratory rats in vivo. Int J Body Composition Res 2009, 7:27-35.
20. Kebede M., Favaloro J., Gunton J.E., Laybutt D.R., Shaw M., Wong N., et al. Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function. Diabetes 2008, 57:1887-1895.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
22. Cai W., He J.C., Zhu L., Chen X., Wallenstein S., Striker G.E., et al. Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression. Am J Pathol 2007, 170:1893-1902.
23. Goldberg T., Cai W., Peppa M., Dardaine V., Baliga B.S., Uribarri J., et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004, 104:1287-1291.
24. Uribarri J., Woodruff S., Goodman S., Cai W., Chen X., Pyzik R., et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010, 110:911 e12-916 e12.
25. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005, 81:341-354.
26. Kahn S.E., Zraika S., Utzschneider K.M., Hull R.L. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009, 52:1003-1012.
27. Coughlan M.T., Yap F.Y.T., Tong D.C.K., Andrikopoulos S., Gasser A., Thallas-Bonke V., et al. Advanced Glycation End Products are Direct Modulators of Beta Cell Function. Diabetes 2011, [Accepted for publication 13th July 2011].
28. Hofmann S.M., Dong H.J., Li Z., Cai W., Altomonte J., Thung S.N., et al. Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 2002, 51:2082-2089.
29. Westerterp K.R., Wilson S.A., Rolland V. Diet induced thermogenesis measured over 24h in a respiration chamber: effect of diet composition. Int J Obes Relat Metab Disord 1999, 23:287-292.
30. Westerterp-Plantenga M.S. Protein intake and energy balance. Regul Pept 2008, 149:67-69.
31. Chen H., Wang Y., Ma L., Zhao J., Li Y., Li M. Long-term high animal protein diet reduces body weight gain and insulin secretion in diet-induced obese rats. J Sci Food Agric 2012.
32. Wang X., Ni S., Xu Y., Liang L., Du L., Gu W. Effects of long-term high-fat/high-energy and high-protein diets on insulin and ghrelin expression in developing rats. Endocr Res 2012, 37:97-109.
33. Wu T., Rayner C.K., Jones K., Horowitz M. Dietary effects on incretin hormone secretion. Vitam Horm 2010, 84:81-110.
34. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87:1409-1439.
35. Knauf C., Cani P.D., Ait-Belgnaoui A., Benani A., Dray C., Cabou C., et al. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 2008, 149:4768-4777.
36. Wein S., Wolffram S., Schrezenmeir J., Gašperiková D., Klimeš I., Šeböková E. Medium-chain fatty acids ameliorate insulin resistance caused by high-fat diets in rats. Diabetes Metab Res Rev 2009, 25:185-194.
37. Zimmet P. Epidemiology of diabetes and its macrovascular manifestations in Pacific populations: the medical effects of social progress. Diabetes Care 1979, 2:144-153.
38. Prior I.A., Davidson F., Salmond C.E., Czochanska Z. Cholesterol, coconuts, and diet on Polynesian atolls: a natural experiment: the Pukapuka and Tokelau island studies. Am J Clin Nutr 1981, 34:1552-1561.
39. Taylor R.J., Bennett P.H., LeGonidec G., Lacoste J., Combe D., Joffres M., et al. The prevalence of diabetes mellitus in a traditional-living Polynesian population: the Wallis Island survey. Diabetes Care 1983, 6:334-340.
40. Greenberger N.J., Rodgers J.B., Isselbacher K.J. Absorption of medium and long chain triglycerides: factors influencing their hydrolysis and transport. J Clin Invest 1966, 45:217-227.
41. Little T.J., Horowitz M., Feinle-Bisset C. Modulation by high-fat diets of gastrointestinal function and hormones associated with the regulation of energy intake: implications for the pathophysiology of obesity. Am J Clin Nutr 2007, 86:531-541.